Reimbursement Briefs: OIG Looks At DME; AHRQ Seeks Imaging Info; MolDx News
This article was originally published in The Gray Sheet
Executive Summary
OIG announces investigation of Medicare’s competitive bidding program in four states and, separately, finds inappropriate and questionable CMS billing for diabetes test strips. AHRQ seeks information about imaging tests for diagnosis and staging of pancreatic cancer. More reimbursement news.
You may also be interested in...
Transparency Advocates Want To Undo Secret Hospital-Insurer Pricing Contracts
Doing away with state insurance laws that protect the privacy of proprietary pricing arrangements between insurers and providers, in a bid to lower procedure prices overall, was a focus of transparency advocates at a recent summit in Washington, D.C.
Reimbursement In Brief
Round two DMEPOS competitive bidding launched July 1 despite efforts by durable medical equipment makers and suppliers to delay it. OIG reports to CMS on continuous positive airway pressure supplies and therapeutic shoes. More reimbursement news.
Personalized Medicine And Palmetto’s MolDx: Raising The Bar On Evidence
Diagnostic industry players support the regional Medicare contractor’s evidence-based reimbursement requirements for molecular diagnostics and are hoping CMS adopts the approach nationally.